Bisphosphonates enhance EGFR-TKIs efficacy in advanced NSCLC patients with EGFR activating mutation: A retrospective study.
Huang CY, Wang L, Feng CJ, Yu P, Cai XH, Yao WX, Xu Y, Liu XK, Zhu WJ, Wang Y, Zhou J, Lu Y, Wang YS.
Huang CY, et al. Among authors: wang l, wang y, wang ys.
Oncotarget. 2016 Oct 11;7(41):66480-66490. doi: 10.18632/oncotarget.5515.
Oncotarget. 2016.
PMID: 26624882
Free PMC article.